In summary, these studies broaden our understanding of macrophage heterogeneity in NASH, identifying a conserved subset expressing TREM-2 and CD9, located in proximity to fibrosis. This evidence concerns the gene CD9 and metabolic dysfunction-associated steatohepatitis.